
Sothema: Revenue Up 17% in the First Half of 2025
In the first half of 2025, Sothema reported a 17% increase in revenue, driven by strong demand in oncology, gastroenterology, cardiology, and psychiatry. The company launched several new products, including a major treatment for multiple sclerosis.










